Moderna seeks CMA for COVID-19 vaccine booster shot in the EU
Moderna has submitted data for a conditional marketing approval (CMA) with the European Medicines Agency (EMA) for the evaluation of a booster dose of its COVID-19 vaccine.
Archives for September 6, 2021
Pfizer takes RSV vaccine candidate into Phase 3 trial
Pfizer has launched a phase 3 trial for its investigational vaccine against respiratory syncytial virus (RSV) in adults aged 60+.
Ardena buys Spain’s Idifarma in move to capitalize on emerging biotech segment
Ardena has acquired Idifarma, a contract manufacturer of niche and highly potent generic and innovative drugs, from Suanfarma; the deal enables it to expand across Southern Europe and supports its strategy to become a leading global CDMO.